Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.63
-0.09 (-0.23%)
At close: Aug 15, 2025, 3:59 PM
38.80
0.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Cytokinetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
66.77M 1.58M 16.93M 463K 249K 835K 1.67M 378K 867K 4.61M 1.96M 2.52M 88.97M 1.15M 55.6M 5.44M 2.84M 6.55M
Cost of Revenue
2.29M 99.84M 93.63M 84.61M 2.41M 2.33M 6.33M 82.53M 83.19M 79.42M 75.02M 62.73M 57.13M 45.94M 43.5M 48.44M 36.44M 31.56M
Gross Profit
64.48M -98.26M -76.7M -84.15M -2.16M -1.5M -4.66M -82.15M -82.33M -74.81M -73.06M -60.22M 31.84M -44.79M 12.1M -43M -33.6M -25.01M
Operating Income
-111.51M -155.63M -139.04M -140.8M -130.17M -126.23M -127.42M -122.27M -122.05M -124.47M -127.03M -108.44M -10.87M -77.86M -21.7M -69.2M -54.8M -40.61M
Interest Income
13M 13.7M 15.01M 17.05M 11.55M 7.91M 7.59M 6.84M 6.78M 6.42M 5.92M 4.14M 864K 415K n/a 231K 187K 290K
Pretax Income
-134.37M -161.38M -150.02M -160.54M -143.32M -135.64M -136.9M -129.42M -128.64M -131.29M -137.38M -142.31M -19.82M -89.44M -30.57M -76.09M -61.55M -47.1M
Net Income
-134.37M -161.38M -150.02M -160.54M -143.32M -135.64M -136.9M -129.42M -128.64M -129.44M -131.46M -176.18M -28.77M -101.03M -30.57M -76.09M -61.55M -47.1M
Selling & General & Admin
65.72M 57.37M 62.34M 56.65M 50.82M 45.5M 44.11M 40.11M 39.72M 49.66M 53.97M 48.22M 42.72M 33.07M 33.81M 26.2M 21.2M 15.6M
Research & Development
112.55M 97.54M 91.25M 463K 77.19M 79.24M 78.64M 378K 867K 2.11M 6.59M 2.52M 968.00 1.15M 43.5M 48.44M 36.44M 31.56M
Other Expenses
-2.29M -97.54M -91.25M -463K n/a n/a n/a -378K 82.33M -2.11M -6.59M -2.52M -968 44.79M 149.37M 48M 33.6M 25.01M
Operating Expenses
175.99M 57.37M 62.34M 56.65M 128.01M 124.74M 122.75M 40.11M 39.72M 49.66M 53.97M 48.22M 42.72M 33.07M 33.81M 26.2M 21.2M 15.6M
Interest Expense
24.27M 22.95M 22.59M 22.3M 24.3M 17.32M 17.06M 14M 13.37M 13.24M 16.27M 15.77M 9.81M 9.31M 8.87M 7.12M 6.94M 6.78M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
178.28M 157.21M 155.97M 141.26M 130.42M 127.07M 129.09M 122.64M 122.92M 129.09M 128.99M 110.96M 99.84M 79M 77.3M 74.64M 57.64M 47.16M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.85M -5.92M 33.87M 8.95M 11.59M n/a -231K 187K 290K
Shares Outstanding (Basic)
119.46M 118.5M 118.08M 117.69M 109.24M 101.92M 99.07M 96.07M 95.75M 95.16M 94.68M 93.76M 85.73M 85M 83.86M 80.09M 71.75M 71.19M
Shares Outstanding (Diluted)
119.46M 118.5M 118.08M 117.69M 109.24M 101.92M 99.07M 96.07M 95.75M 95.16M 94.68M 93.76M 85.73M 85M 84.09M 80.33M 71.75M 71.19M
EPS (Basic)
-1.12 -1.36 -1.27 -1.36 -1.31 -1.33 -1.38 -1.35 -1.34 -1.36 -1.39 -1.88 -0.34 -1.19 -0.36 -0.95 -0.86 -0.66
EPS (Diluted)
-1.12 -1.36 -1.27 -1.36 -1.31 -1.33 -1.38 -1.35 -1.34 -1.36 -1.39 -1.88 -0.34 -1.19 -0.36 -0.95 -0.86 -0.66
EBITDA
-107.82M -136.13M -125.04M -135.84M -116.61M -115.99M -113.5M -113.57M -112.48M -115.27M -118.37M -124.45M -8.01M -78.57M -19.39M -68.51M -54.07M -39.78M
EBIT
-110.11M -138.43M -127.43M -138.25M -119.02M -118.32M -119.83M -115.43M -115.27M -118.05M -121.11M -126.54M -10.01M -80.14M -22.08M -68.97M -54.61M -40.32M
Depreciation & Amortization
2.29M 2.3M 2.38M 2.41M 2.41M 2.33M 6.33M 1.85M 2.79M 2.78M 2.74M 2.09M 2M 1.57M 2.69M 5.87M 543K 537K